Elie G. Dib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Elie G. Dib
May 17, 2024, 12:54 |
Insight
Piotr Wysocki: Anti-HER2 treatment in patients with advanced biliary cancer
Piotr Wysocki recently posted on LinkedIn: "The Targeted Agent and Profiling Utilization Registry (TAPUR) Study is…
May 16, 2024, 14:15 |
Insight
Elie G. Dib: Excited to share the results of the TAPUR study
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital,…
Apr 20, 2024, 14:21 |
Blog
Elie G. Dib: An article I co-authored with Dr. Shah and Dr. Robert Fontana and team on drug-induced liver injury in cancer treatment
Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital, posted…
Apr 11, 2024, 07:39 |
Blog
Elie G. Dib: In our recent article we assigned genomic alterations to each hallmark and uncovered some intriguing patterns
Quoting Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy…
Oct 4, 2023, 17:41 |
Insight
Elie G. Dib: Huge shout-out to Dr. Brad Zebrack for spearheading this innovative research exemplifying the future of survivorship science!
Quoting Elie G. Dib, Associate Director of The Haematology Oncology training program at Saint Joseph…
Sep 14, 2023, 18:40 |
Career
Elie G. Dib: I'm deeply honored to receive the National Cancer Institute's Gold Certificate of Excellence for exceptional achievement in patient enrollments in NCI treatment, cancer control, prevention, and screening trials.
Aug 10, 2023, 04:52 |
Blog
World-renowned cancer experts, young oncology leaders and prominent patient advocates join the Editorial Board of OncoDaily
It is a great pleasure to introduce the new Editorial Board Members of OncoDaily.com! World-renowned…
Jun 15, 2023, 15:56 |
Drugs
Patients with ERBB2 exon 20 insertion mutations showed particularly encouraging outcomes - Elie G. Dib
Excited to share that our study, published in JCO Precision Oncology, sheds light on the…
All:
8
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube